Sutro Biopharma, Inc. (STRO)
21.44
+0.95
(+4.64%)
USD |
NASDAQ |
Aug 25, 16:00
21.39
-0.05
(-0.23%)
After-Hours: 19:59
Sutro Biopharma Shareholders Equity (Quarterly) : -103.32M for June 30, 2026
Shareholders Equity (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Shareholders Equity (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | -103.32M |
| March 31, 2026 | -66.89M |
| December 31, 2025 | -132.45M |
| September 30, 2025 | -87.27M |
| June 30, 2025 | -32.11M |
| March 31, 2025 | -25.81M |
| December 31, 2024 | 44.60M |
| September 30, 2024 | 111.22M |
| June 30, 2024 | 152.18M |
| March 31, 2024 | 98.02M |
| December 31, 2023 | 149.65M |
| September 30, 2023 | 112.35M |
| June 30, 2023 | 154.72M |
| March 31, 2023 | 185.41M |
| December 31, 2022 | 217.05M |
| September 30, 2022 | 229.73M |
| June 30, 2022 | 209.06M |
| March 31, 2022 | 220.37M |
| Date | Value |
|---|---|
| December 31, 2021 | 252.56M |
| September 30, 2021 | 283.58M |
| June 30, 2021 | 307.50M |
| March 31, 2021 | 307.34M |
| December 31, 2020 | 332.05M |
| September 30, 2020 | 244.12M |
| June 30, 2020 | 206.76M |
| March 31, 2020 | 82.08M |
| December 31, 2019 | 97.79M |
| September 30, 2019 | 109.91M |
| June 30, 2019 | 119.56M |
| March 31, 2019 | 130.72M |
| December 31, 2018 | 131.54M |
| September 30, 2018 | 45.81M |
| June 30, 2018 | |
| March 31, 2018 | |
| December 31, 2017 | -6.288M |
Shareholders' Equity Definition
Represents the value of Shareholders' Equity as of the close of the report date, belonging to both Preferred and Common Equity Shareholders.
Shareholders Equity (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Shareholders Equity (Quarterly) Benchmarks
| Praxis Precision Medicines, Inc. | 1.341B |
| Upstream Bio, Inc. | 270.96M |
| ACADIA Pharmaceuticals, Inc. | 1.307B |
| Alnylam Pharmaceuticals, Inc. | 1.354B |
| Anika Therapeutics, Inc. | 137.28M |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 194.46M |
| Total Liabilities (Quarterly) | 297.78M |
| Debt to Equity Ratio | -2.418 |
| Current Ratio | 3.320 |
| Net Debt Paydown Yield | -1.39% |